Beckman Coulter, Inc., has launched a new benchtop hematology analyzer for mid- to high-volume laboratories. Building on the company’s cellular analysis technology, Beckman Coulter’s new UniCel DxH 600 Coulter cellular analysis system—with recently FDA-cleared advanced software—provides laboratories with quality results, improved first-pass accuracy, and automatic rerun and reflex testing, thereby reducing overall manual review rates and processes.
According to company representatives, the robust software with which the UniCel DxH 600 is equipped provides new features, enhancements, and research-use parameters to improve laboratory efficiency, reliability, and quality. The software saves time by allowing labs to partially release patient results manually or automatically via decision rules. In addition, it gives users the ability to create and edit decision rules during instrument operation and utilize pre-defined decision rules using Cell Population Data (for research use only). Additional features include the ability to track workload by day, hour, and test, as well as to provide automatic notification of STAT samples that have not been processed or released within an expected time frame.
With the same technology, user interface, and consumables as the UniCel DxH 800 Coulter cellular analysis system, the UniCel DxH 600 brings standardization of results and process to the hematology laboratory, reducing personnel training and simplifying consumable inventory management. All new DxH 800 analyzers will be installed with the advanced software, and current DxH 800 customers will be upgraded. Learn more about Beckman Coulter hematology solutions.
